Clinical Trial: Effects of Hemp-Derived Cannabinoids on Menopause Symptoms

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393672) titled 'Effects of Hemp-Derived Cannabinoids on Menopause Symptoms' on Jan. 30.

Brief Summary: The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: Menopause Perimenopause

Intervention: DRUG: Hemp-derived cannabinoids

Participants will be administered a legal product with hemp-derived cannabinoids and terpenes.

DRUG: Placebo

Participants will be administered a placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Washington State University

Information provided by (Responsible Party): Carrie Cu...